Study of eravacycline in seriously ill patients
Part of Infections clinical trials.
This study looks at how well the antibiotic eravacycline works in seriously ill patients who have not improved with other antibiotics. It aims to understand how the drug behaves in the body to help guide dosing and improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- Be seriously ill and in the hospital
- Have an infection that did not get better with initial antibiotics
- Be treated with eravacycline for at least 3 days
- Be able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination treatment using eravacycline, an antibiotic, for pneumonia caused by bacteria that are resistant to many other antibiotics. It aims to see if this treatment can help patients who have not responded to standard care.
This Phase 2 study tests whether taking Xerava (an antibiotic) can prevent serious infections in people who have prolonged low neutrophils after chemotherapy or transplant preparation. If it works, it may lower the risk of infections during the highest-risk period after treatment.
This trial tests an antibiotic called eravacycline for children (ages 8–17) with serious belly infections. The medicine is given through an IV in the hospital to see if it is safe and tolerable.
This trial tests a specific antibiotic combination (ceftazidime-avibactam) in patients with serious infections that are resistant to other antibiotics, while they are in intensive care. The goal is to see how well this treatment works for critically ill patients.
This study looks at how a certain antibiotic (ceftazidime-avibactam) works in people with blood cancers or stem cell transplants, and how the drug levels affect the bacteria. It aims to find the best dosing to fight infections and reduce resistance.
This trial tests whether measuring drug levels in the blood can help doctors give the right dose of ceftazidime-avibactam (an antibiotic) to patients with hard-to-treat infections in the ICU, potentially improving treatment outcomes and reducing side effects.
Hear when a new Eravacycline trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.